Welcome to Frugi Biotechnology Inc.
|
A wholly-owned subsidiary of BigHat Biosciences |
|
|
Cell free expression (CFE) has the potential to unlock advanced diagnostic and drug discovery platforms. Our focus is to make the most cost-effective and reliable expression system available for these applications.
|
|
Funded by NSF Award# 2112144
"SBIR Phase I: Modular, Paper-based, Secured Diagnostics for Managing Viral Outbreaks (COVID-19)" Matching grant by Iowa Economic Development Authority |
Cell Free for Diagnostics |
Cell Free for Drug Discovery |
|
SARS-COV-2 (COVID-19)
HIV Influenza |
Antibodies
Enzymes |
Frugi = frugal
Our Story
|
Our initial focus on frugal cell free extract was founded in development of a paper-based, mail-safe platform which was supported by a RAPID NSF PFI project conducted at Iowa State University (read full abstract here). The underlying cell free components are the current research and product focus. ISU NEWS FIERCE ELECTRONICS BIOSPACE NEWS Or watch these news clips: |
|
|
|
|